2016
DOI: 10.18203/2320-1770.ijrcog20161707
|View full text |Cite
|
Sign up to set email alerts
|

Utility of fasting plasma glucose test as screening tool for gestational diabetes mellitus based on International Association of the Diabetes and Pregnancy Study Group criteria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…[14] Untreated GDM results in adverse maternal and fetal outcomes such as increased risk of preterm delivery, preeclampsia, macrosomia or large for gestational age (a known risk factor for birth injury), operative delivery, stillbirth, respiratory distress syndrome, and neonatal hypoglycaemia. [15] The oral glucose tolerance test (OGTT) is considered to be the gold standard for diagnosis of GDM and is superior to fasting plasma glucose (FPG) and the glycosylated haemoglobin (HbA1c) level. [16] However, the OGTT has its limitations including cost, the time required for the test and the unpleasant side-effects due to the high glucose load.…”
mentioning
confidence: 99%
“…[14] Untreated GDM results in adverse maternal and fetal outcomes such as increased risk of preterm delivery, preeclampsia, macrosomia or large for gestational age (a known risk factor for birth injury), operative delivery, stillbirth, respiratory distress syndrome, and neonatal hypoglycaemia. [15] The oral glucose tolerance test (OGTT) is considered to be the gold standard for diagnosis of GDM and is superior to fasting plasma glucose (FPG) and the glycosylated haemoglobin (HbA1c) level. [16] However, the OGTT has its limitations including cost, the time required for the test and the unpleasant side-effects due to the high glucose load.…”
mentioning
confidence: 99%